InvestorsHub Logo
Followers 680
Posts 141212
Boards Moderated 36
Alias Born 03/10/2004

Re: None

Saturday, 08/06/2022 3:46:23 PM

Saturday, August 06, 2022 3:46:23 PM

Post# of 613
Oppenheimer Equities Analysts Reduce Earnings Estimates for CVS Health Co. (CVS)
By: MarketBeat | August 5, 2022

• CVS Health Co. (NYSE:CVS - Get Rating) - Research analysts at Oppenheimer decreased their Q3 2022 earnings per share (EPS) estimates for CVS Health in a report issued on Wednesday, August 3rd. Oppenheimer analyst M. Wiederhorn now forecasts that the pharmacy operator will post earnings of $2.00 per share for the quarter, down from their prior estimate of $2.03. The consensus estimate for CVS Health's current full-year earnings is $8.57 per share. Oppenheimer also issued estimates for CVS Health's Q4 2022 earnings at $1.96 EPS, FY2022 earnings at $8.57 EPS, Q2 2023 earnings at $2.40 EPS, Q4 2023 earnings at $2.19 EPS, FY2023 earnings at $9.04 EPS and FY2024 earnings at $9.92 EPS...

Read Full Story »»»

DiscoverGold

Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVS News